Bio-Rad Labs (BIO) Tops Q2 EPS by 19c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $380.12 -1.55%
EPS Growth %: +5.3%
Financial Fact:
Net income per share diluted attributable to Bio-Rad: 0.61
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +5.3%
Financial Fact:
Net income per share diluted attributable to Bio-Rad: 0.61
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $0.97, $0.19 better than the analyst estimate of $0.78. Revenue for the quarter came in at $506.1 million versus the consensus estimate of $494.85 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- GameStop beats second quarter estimates on collectibles
- BMO Capital Starts Lululemon (LULU) at Underperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
